Cargando…
Identification of GSPT1 as prognostic biomarker and promoter of malignant colon cancer cell phenotypes via the GSK-3β/CyclinD1 pathway
Colon cancer is the third most common malignant tumor and its mortality rate ranks fourth among all malignant tumor types. Bioinformatics analysis has shown that GSPT1 is dysregulated in colon cancer and is associated with tumor progression. However, the underlying mechanism remains unclear. To addr...
Autores principales: | Long, Xuan, Zhao, Lijun, Li, Guoqiang, Wang, Ziwei, Deng, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064227/ https://www.ncbi.nlm.nih.gov/pubmed/33819920 http://dx.doi.org/10.18632/aging.202796 |
Ejemplares similares
-
CyclinD1, a prominent prognostic marker for endometrial diseases
por: Liang, Shuo, et al.
Publicado: (2013) -
CCN1 stimulated the osteoblasts via PTEN/AKT/GSK3β/cyclinD1 signal pathway in Myeloma Bone Disease
por: Yan, Siyang, et al.
Publicado: (2019) -
USP5 Sustains the Proliferation of Glioblastoma Through Stabilization of CyclinD1
por: Li, Gen, et al.
Publicado: (2021) -
Role of GSPT1 and GSPT2 polymorphisms in different outcomes upon Hepatitis B virus infection and prognosis to lamivudine therapy
por: Liu, Wenxuan, et al.
Publicado: (2019) -
The Overexpression of CARM1 Promotes Human Osteosarcoma Cell Proliferation through the pGSK3β/β-Catenin/cyclinD1 Signaling Pathway
por: Li, Shijie, et al.
Publicado: (2017)